Social network
  • Visit We R Hope page

    We R Hope by Sanofi

  • Fighting dengue ferver

    Fighting dengue ferver

  • Meet Anne-Olivier Bandini: R&D Team Leader, France

  • Isabelle, Type 1 diabetes, France

    Isabelle, Type 1 diabetes, France


    Our mission: Shaping tomorrow’s health

    As researchers, we have it in us to be extraordinary bold and hopeful because in research what will happen ten or fifteen years from now is going to be determined by what we do today. We have the power to bring an idea from a scientist’s mind directly to patients.

    From Science to Solutions

    Scientific and medical advances are extraordinary, and we in R&D, are committed to transforming this new knowledge into healthcare solutions for patients. Over the past decades, we have achieved tremendous efforts in biomedical research and have progressed in controlling infectious diseases for instance. However, as people live longer, they now suffer from more complex and chronic diseases, such as diabetes, cancer or cardiovascular diseases. These diseases remain difficult to treat effectively, hence the necessity to find ways to accelerate the development of new, more effective and better tolerated health solutions for patients. At the heart of our job is high-quality and rigorous science combined with a passion to understand patients’ needs and develop the solutions that will improve their lives.


    Understanding the needs of patients better

    At Sanofi, we are convinced that to be truly innovative and to bring better treatment options to patients, we must understand their needs and how their disease affects their day to day lives. Who is better placed to define gaps in treatments than those living with a particular disease or those who advocate for them? Through their insights, we develop medicines that better fit their needs.

    Our aim is to connect fundamental research (based on biological and animal models) and clinical research (focused on human beings) to facilitate the transfer of recent scientific discoveries to the clinical care of patients. This way, we will accelerate the provision of better, more effective and targeted treatments. The success of this approach requires increased collaboration between our researchers, physicians and clinical research centers.


    As researchers, we have it in our hands today to change health tomorrow. We can bring an idea from a scientist’s mind directly to patients – be it through a vaccine that can save millions of lives or through a rare disease therapy that touches one life at a time.

    Elias Zerhouni, President Global R&D, Sanofi

    Engaging Patients in R&D

    Partners in Patient Health is a novel approach of ongoing dialogue across patient and advocacy communities to share perspectives, generate ideas, and find new ways of working together to make a more substantial impact on patients’ health. The problems facing patients today are too complex for any one organization to solve. Partners in Patient Health focuses on three issues common to all patients and the advocacy community:

    • Health
    • Policy
    • Innovation

    By working together in new ways, advocates can elevate the patient’s voice throughout the healthcare system.

    Right area: